SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia
NEW YORK, NY (August 28, 2018)—TB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether
Press Releases
TB Alliance Statement on WHO Rapid Communication Regarding MDR-TB Treatment
TB Alliance congratulates the World Health Organization on the issuance of its rapid communication informing all stakeholders about the key
TB Alliance Names Angela Vanderploeg as Chief Financial Officer
NEW YORK (July 13, 2018) – TB Alliance today announced the appointment of Angela Vanderploeg as Chief Financial Officer. Ms.
News
In Memory of Professor Denis Mitchison
It was with great sadness that we received the news of Professor Denis Mitchison’s passing at the age of 98
Statement on Civil Society Hearing on the UN High Level Meeting on Tuberculosis
On 4 June 2018, TB Alliance participated in the Interactive Civil Society Hearing as part of the preparatory process towards
News
TB Alliance Names Sandeep Juneja as Senior Vice President for Market Access
NEW YORK (June 4, 2018) – TB Alliance today announced the appointment of Sandeep Juneja to Senior Vice President for
Global MPs Urge Heads of State to Act on Tuberculosis
NEW YORK (April 26, 2018) – In a statement released on Thursday, members of the Global TB Caucus, a group
Nancy Miller-Rich Joins TB Alliance Board of Directors
NEW YORK (March 6, 2018)—TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis
ZeNix Clinical Trial Announced
NEW YORK (7 February, 2018) — TB Alliance has announced the start of a clinical trial of a three-drug regimen
Ending TB Means Investing in R&D
This week, as health ministers, diplomats and other representatives meet to discuss tuberculosis (TB) at the World Health Organization (WHO)